For decades, India’s role in pharma research was restricted to the role of a cost-effective destination for late-stage clinical trials. But now with Novartis, India will become the next pharma research capital.
Lupin Q4 profit, US sales growth, and strong revenue momentum remained in focus after the pharmaceutical company reported an 87.7% jump in consolidated net profit to Rs 1,468.7 crore for the fourth quarter of FY2026. The impressive performan...
Capital Utilisation and Profitability have become the key focus areas for Biocon as the company moves beyond its aggressive expansion phase and shifts attention toward improving margins and operational efficiency.
Dr Reddy’s and Nestlé Health Science have strengthened their presence in India’s growing obesity nutrition care market with the launch of Celevida GLP+, a nutrition supplement designed for people using GLP-1 and GIP-based therapies for obesity...
New research on weight loss drugs suggests these medications may affect more than appetite and body weight. Scientists have found that newer GLP-1-based treatments could alter the brain’s reward system, potentially changing how people experience...
The medical devices sector in India received a major push after the (YEIDA) signed a memorandum of understanding with (MEJ) to strengthen manufacturing, technology transfer, and investment in the industry.
Star Health is expanding its affordable health insurance plans across tier-2 and tier-3 cities as the company looks to tap into rising healthcare awareness in smaller towns. The insurer’s latest move reflects the growing demand for low-cost heal...
Leadership changes often mark the end of an era. At Biocon, it signals continuity. As Kiran Mazumdar-Shaw chose Claire Mazumdar as her successor, the message was clear. This is not about stepping away. It’s about making sure the mission stays intact.
A Liquid Biopsy Test could reshape how cancer is detected in India, where a large number of cases are still diagnosed at advanced stages. Limited access to routine screening, lack of awareness, and reliance on invasive procedures have long...
Eli Lilly and Company reports a significant shift in Ulcerative Colitis (UC) treatment, with Omvoh sustaining disease clearance in patients for more than four years, setting a new standard in UC care.
, CDSCO.jpg)